40 II-Analyse des facteurs pronostiques, p.41 ,
Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients, New England Journal of Medicine, vol.347, issue.7, pp.488-96, 2002. ,
DOI : 10.1056/NEJMoa020439
Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction, American Journal of Transplantation, vol.27, issue.3, pp.582-94, 2005. ,
DOI : 10.1016/S1053-2498(02)01159-2
Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review, Mod Pathol, vol.9, issue.2, pp.105-114, 1996. ,
BK-virus nephropathy in renal transplants--tubular necrosis, MHC-class II expression and rejection in a puzzling game, Nephrology Dialysis Transplantation, vol.15, issue.3, pp.324-356, 2000. ,
DOI : 10.1093/ndt/15.3.324
Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations, Transplantation, vol.79, issue.10, pp.1277-86, 2005. ,
DOI : 10.1097/01.TP.0000156165.83160.09
BK Virus Infection in Transplant Recipients: An Overview and Update, American Journal of Transplantation, vol.40, issue.9, pp.2000-2005, 2006. ,
DOI : 10.1111/j.1600-6143.2005.01137.x
BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program, Clin Transpl, pp.143-53, 2002. ,
BK Virus in Solid Organ Transplant Recipients, American Journal of Transplantation, vol.87, issue.supl 2, pp.136-182, 2009. ,
DOI : 10.1111/j.1600-6143.2009.02904.x
NEW HUMAN PAPOVAVIRUS (B.K.) ISOLATED FROM URINE AFTER RENAL TRANSPLANTATION, The Lancet, vol.297, issue.7712, pp.1253-1260, 1971. ,
DOI : 10.1016/S0140-6736(71)91776-4
Polyomavirus BK, The Lancet Infectious Diseases, vol.3, issue.10, pp.611-634, 2003. ,
DOI : 10.1016/S1473-3099(03)00770-9
Monitoring of BK Viral Load in Renal Allograft Recipients by Real-Time PCR Assays, American Journal of Clinical Pathology, vol.133, issue.2, pp.242-50, 2010. ,
DOI : 10.1309/AJCP63VDFCKCRUUL
MR Imaging of BK virus encephalitis, AJNR Am J Neuroradiol, vol.27, issue.5, pp.1016-1024, 2006. ,
Delirium in a Renal Transplant Recipient Associated with BK Virus in the Cerebrospinal Fluid, Transplantation, vol.78, issue.9, pp.1407-1415, 2004. ,
DOI : 10.1097/01.TP.0000137106.09925.8B
BK Virus: Opportunity Makes a Pathogen, Clinical Infectious Diseases, vol.41, issue.3, pp.354-60, 2005. ,
DOI : 10.1086/431488
URL : http://cid.oxfordjournals.org/cgi/content/short/41/3/354
hybridization study, Pediatric Transplantation, vol.7, issue.5, pp.600-605, 2008. ,
DOI : 10.1111/j.1399-3046.2007.00855.x
Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent, Transplantation, vol.73, issue.12, pp.1933-1939, 2002. ,
DOI : 10.1097/00007890-200206270-00015
BK and JC Viruses in Patients with Systemic Lupus Erythematosus: Prevalent and Persistent BK Viruria, Sequence Stability of the Viral Regulatory Regions, and Nondetectable Viremia, The Journal of Infectious Diseases, vol.180, issue.1, pp.1-9, 1999. ,
DOI : 10.1086/314830
A comparative study of BK and JC virus infections in organ transplant recipients, Journal of Medical Virology, vol.74, issue.2, pp.238-281, 2005. ,
DOI : 10.1002/jmv.20442
Infections virales In: Noël LH Atlas de pathologie rénale, Paris: Flammarion Medecine-Sciences, pp.875-885, 2008. ,
BK virus infection: an update on diagnosis and treatment, Nephrology Dialysis Transplantation, vol.30, issue.2, pp.209-226, 2015. ,
DOI : 10.1093/ndt/gfu023
BK Virus Nephropathy and Kidney Transplantation, Clinical Journal of the American Society of Nephrology, vol.2, issue.Supplement 1, pp.36-46, 2007. ,
DOI : 10.2215/CJN.00920207
Polyoma and Papilloma Virus Infections after Hematopoietic Cell or Solid Organ Transplantation, pp.468-978, 2010. ,
Cellular immune responses to BK virus, Current Opinion in Organ Transplantation, vol.13, issue.6, pp.569-74, 2008. ,
DOI : 10.1097/MOT.0b013e3283186b93
Clinical Course of Polyoma Virus Nephropathy in 67 Renal Transplant Patients, Journal of the American Society of Nephrology, vol.13, issue.8, pp.2145-51, 2002. ,
DOI : 10.1097/01.ASN.0000023435.07320.81
Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States, Transplant International, vol.84, issue.Suppl. 1, pp.626-660, 2009. ,
DOI : 10.1111/j.1432-2277.2009.00842.x
HLA Mismatching Increases the Risk of BK Virus Nephropathy in Renal Transplant Recipients, American Journal of Transplantation, vol.266, issue.10, pp.1691-1697, 2004. ,
DOI : 10.1097/00007890-200204270-00030
Incidence and Outcomes of BK Virus Allograft Nephropathy among ABO- and HLA-Incompatible Kidney Transplant Recipients, Clinical Journal of the American Society of Nephrology, vol.7, issue.8, pp.1320-1327, 2012. ,
DOI : 10.2215/CJN.00770112
Donor Origin of BK Virus in Renal Transplantation and Role of HLA C7 in Susceptibility to Sustained BK Viremia, American Journal of Transplantation, vol.9, issue.9, pp.2213-2234, 2005. ,
DOI : 10.1016/S0041-1345(03)00818-2
BK Polyomavirus in Solid Organ Transplantation, American Journal of Transplantation, vol.9, issue.Suppl 4, pp.179-88, 2013. ,
DOI : 10.1111/ajt.12110
Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study, American Journal of Transplantation, vol.13, issue.5 Pt 2, pp.136-181, 2013. ,
DOI : 10.1111/j.1600-6143.2012.04320.x
Pathology of Resolving Polyomavirus-Associated Nephropathy, American Journal of Transplantation, vol.30, issue.6, pp.1474-83, 2013. ,
DOI : 10.1111/ajt.12218
Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load, American Journal of Transplantation, vol.308, issue.6, pp.2082-92, 2004. ,
DOI : 10.1086/383034
Polyoma Virus Infection, American Journal of Kidney Diseases, vol.37, issue.1, pp.1-2, 2001. ,
DOI : 10.1053/S0272-6386(13)90036-6
Polyomaviruses and disease, Current Opinion in Organ Transplantation, vol.20, issue.3, pp.348-58, 2015. ,
DOI : 10.1097/MOT.0000000000000192
Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy, American Journal of Transplantation, vol.24, issue.Suppl 4, pp.2615-2638, 2010. ,
DOI : 10.1111/j.1600-6143.2010.03310.x
Prospective Monitoring of Polyomavirus BK Replication and Impact of Pre-Emptive Intervention in Pediatric Kidney Recipients, American Journal of Transplantation, vol.7, issue.12, pp.2727-2762, 2007. ,
DOI : 10.1111/j.1600-6143.2005.01096.x
Kidney Transplant Function and Histological Clearance of Virus Following Diagnosis of Polyomavirus-Associated Nephropathy (PVAN), American Journal of Transplantation, vol.5, issue.Suppl 4, pp.1025-1057, 2006. ,
DOI : 10.1111/j.1600-6143.2006.01296.x
Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults1, Transplantation, vol.75, issue.1, pp.105-117, 2003. ,
DOI : 10.1097/00007890-200301150-00020
Adjuvant Low-Dose Cidofovir Therapy for BK Polyomavirus Interstitial Nephritis in Renal Transplant Recipients, American Journal of Transplantation, vol.10, issue.4, pp.1997-2004, 2005. ,
DOI : 10.1016/j.virol.2004.03.027
The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients, Nephrology Dialysis Transplantation, vol.24, issue.3, pp.1034-1042, 2009. ,
DOI : 10.1093/ndt/gfn675
Treatment of Renal Allograft Polyoma BK Virus Infection with Leflunomide, Transplantation, vol.81, issue.5, pp.704-714, 2006. ,
DOI : 10.1097/01.tp.0000181149.76113.50
Intravenous Immunoglobulin as a Treatment for BK Virus Associated Nephropathy: One-Year Follow-Up of Renal Allograft Recipients, Transplantation, vol.81, issue.1, pp.117-137, 2006. ,
DOI : 10.1097/01.tp.0000181096.14257.c2
Evaluation of Fluoroquinolones for the Prevention of BK Viremia after Renal Transplantation, Clinical Journal of the American Society of Nephrology, vol.5, issue.7, pp.1298-304, 2010. ,
DOI : 10.2215/CJN.08261109
Levofloxacin for BK Virus Prophylaxis Following Kidney Transplantation, JAMA, vol.312, issue.20, pp.2106-2120, 2014. ,
DOI : 10.1001/jama.2014.14721
BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients, Kidney International, vol.68, issue.4, pp.1834-1843, 2005. ,
DOI : 10.1111/j.1523-1755.2005.00602.x
Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis, and Graft Function Following Changes in Immunosuppression, American Journal of Transplantation, vol.10, issue.11, pp.1378-82, 2003. ,
DOI : 10.1086/320711
BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results, American Journal of Transplantation, vol.88, issue.2, pp.407-422, 2010. ,
DOI : 10.1111/j.1600-6143.2009.02952.x
Incorporation of Pathology and Laboratory Findings Into Management Algorithms for Polyomavirus Nephropathy, American Journal of Transplantation, vol.94, issue.6, pp.1379-81, 2013. ,
DOI : 10.1111/ajt.12226
Putative Episodes of T-Cell???Mediated Rejection in Patients With Sustained BK Viruria but No Viremia, Transplantation Journal, vol.94, issue.1, pp.43-52, 2012. ,
DOI : 10.1097/TP.0b013e318253e7a4
Current problems in screening, diagnosis and treatment of polyomavirus BK nephropathy, Nephrology, vol.26, issue.Suppl 24, pp.11-17, 2014. ,
DOI : 10.1111/nep.12254
Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring, Transplantation Journal, vol.95, issue.12, pp.1498-505, 2013. ,
DOI : 10.1097/TP.0b013e3182921995
/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience, Transplant Infectious Disease, vol.43, issue.4, pp.55-60, 2014. ,
DOI : 10.1111/tid.12164
Persistent BK Viremia Does Not Increase Intermediate-Term Graft Loss but Is Associated with De Novo Donor-Specific Antibodies, Journal of the American Society of Nephrology, vol.26, issue.4, pp.966-975, 2015. ,
DOI : 10.1681/ASN.2014010119
Rapport médical et scientifique du prélèvement et de la greffe en France, bilan en, 2011. ,
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation, New England Journal of Medicine, vol.357, issue.25, pp.2562-75, 2007. ,
DOI : 10.1056/NEJMoa067411
Management and Outcome of BK Viremia in Renal Transplant Recipients, Transplantation Journal, vol.94, issue.8, pp.814-835, 2012. ,
DOI : 10.1097/TP.0b013e31826690c6
Clinical Utility of Histological Features of Polyomavirus Allograft Nephropathy, Transplantation, vol.82, issue.2, pp.196-204, 2006. ,
DOI : 10.1097/01.tp.0000226176.87700.a4
Factors Influencing Viral Clearing and Renal Function During Polyomavirus BK???Associated Nephropathy After Renal Transplantation, Transplantation Journal, vol.94, issue.4, pp.396-402, 2012. ,
DOI : 10.1097/TP.0b013e31825a505d
Polyomavirus Nephropathy, Transplantation, vol.99, issue.3, pp.609-624, 2015. ,
DOI : 10.1097/TP.0000000000000367
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347732
Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy, Kidney International, vol.64, issue.2, pp.665-73, 2003. ,
DOI : 10.1046/j.1523-1755.2003.00103.x
Antirejection Treatment in Kidney Transplant Patients with BK Viruria, Transplantation, vol.86, issue.6, pp.797-803, 2008. ,
DOI : 10.1097/TP.0b013e3181837802
Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity, Clinical and Developmental Immunology, vol.345, issue.8941, p.256923, 2013. ,
DOI : 10.1016/j.virusres.2011.07.017
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant, American Journal of Transplantation, vol.11, issue.5, pp.1157-67, 2012. ,
DOI : 10.1111/j.1600-6143.2012.04013.x
De Novo Donor Specific Antibody (DSA) After Treatment of BK Infection With Intravenous Immunoglobulin (IVIG) American Transplant Congress, 2015. ,
BK Virus-Specific Immunity Kinetics: A Predictor of Recovery From Polyomavirus BK-Associated Nephropathy, American Journal of Transplantation, vol.5, issue.Suppl 4, pp.2443-52, 2011. ,
DOI : 10.1111/j.1600-6143.2011.03693.x
Notre étude est descriptive de la population rouennaise greffée rénale ayant présenté une virémie BK >10^3 copies/mL entre Est associée une analyse de survie, avec mise en évidence de facteurs pronostiques d'évolution défavorable du greffon, définie par une majoration de la créatininémie, 2008. ,
évolution du greffon est défavorable dans 40,4% des cas, avec un délai moyen de 40,4 mois. Les survies du greffon et patient sont respectivement à 87, pp.7-895 ,
Le traitement est secondairement majoré dans 43,9% des cas Après clairance virale, le taux de rejets est à 19,3%, 8/11 rejets ont une composante humorale. Un donneur plus âgé (HR:1,1; p=0,009) et la survenue d'un rejet après clairance virale (HR:3,5; p=0,008) sont, en analyse multivariée ,